Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [21] Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
    Schiavoni, Valentina
    Campagna, Roberto
    Pozzi, Valentina
    Cecati, Monia
    Milanese, Giulio
    Sartini, Davide
    Salvolini, Eleonora
    Galosi, Andrea Benedetto
    Emanuelli, Monica
    CANCERS, 2023, 15 (12)
  • [22] Emerging Targets in Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    Beckermann, Kathryn E.
    CANCERS, 2022, 14 (19)
  • [23] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Hugues, Marion
    Nerich, V
    Nai, T.
    Paillard, M. J.
    Borowski, L.
    Stein, U.
    Hon, Nguyen Tan T.
    Montcuquet, P.
    Maurina, T.
    Mouillet, G.
    Kleinclauss, F.
    Pivot, X.
    Thiery-Vuillemin, A.
    Limat, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 271 - 271
  • [24] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [25] ECONOMIC EVALUATION OF TARGETED THERAPIES IN METASTATIC CLEAR RENAL CELL CARCINOMA IN CANADA
    Nazha, S.
    Prevost, N.
    Tanguay, S.
    Vanhuyse, M.
    Dragomir, A.
    VALUE IN HEALTH, 2016, 19 (07) : A727 - A727
  • [26] HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
    Maroto, P.
    Esteban, E.
    Fernandez Parra, E.
    Mendez-Vidal, M. J.
    Domenech, M.
    Perez-Valderrama, B.
    Calderero, V.
    Perez-Gracia, J. L.
    Grande, E.
    Algaba, F.
    ONCOTARGETS AND THERAPY, 2017, 10 : 4635 - 4642
  • [27] First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options
    Vivian Loo
    Meghan Salgia
    Paulo Bergerot
    Errol J. Philip
    Sumanta K. Pal
    Targeted Oncology, 2019, 14 : 639 - 645
  • [28] First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options
    Loo, Vivian
    Salgia, Meghan
    Bergerot, Paulo
    Philip, Errol J.
    Pal, Sumanta K.
    TARGETED ONCOLOGY, 2019, 14 (06) : 639 - 645
  • [29] Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
    Miao, Diana
    Margolis, Claire A.
    Gao, Wenhua
    Voss, Martin H.
    Li, Wei
    Martini, Dylan J.
    Norton, Craig
    Bosse, Dominick
    Wankowicz, Stephanie M.
    Cullen, Dana
    Horak, Christine
    Wind-Rotolo, Megan
    Tracy, Adam
    Giannakis, Marios
    Hodi, Frank Stephen
    Drake, Charles G.
    Ball, Mark W.
    Allaf, Mohamad E.
    Snyder, Alexandra
    Hellmann, Matthew D.
    Ho, Thai
    Motzer, Robert J.
    Signoretti, Sabina
    Kaelin, William G., Jr.
    Choueiri, Toni K.
    Van Allen, Eliezer M.
    SCIENCE, 2018, 359 (6377) : 801 - 805
  • [30] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
12345